COVID-19 Vaccines Webinar

ISAC COVID-19 Vaccines Webinar

22 February 2020 at 13.30 (GMT)

This timely ISAC webinar will review the three major vaccine candidates currently licensed for use. Three experts in their field who are also involved in their national vaccination programmes will each cover one of the vaccine types. This is a webinar for everyone including all infection specialists. The COVID-19 pandemic affects us all and it is important that we understand the new vaccines that are now available.

**Please note that attendees will be able to download a certificate of attendance during the webinar.

Speaker Bios

Andreas Voss is a Consultant Microbiologist and Professor of Infection Control at Radboudumc Center for Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. Andreas is a true IPC expert and his research focuses on improving infection prevention and hygiene in hospitals. He specialises in the epidemiology and prevention of multi-resistant hospital bacteria, such as MRSA, VRE, ESBL and CPE. He is particularly interested in hand hygiene, especially in replacing hand washing and introducing bedside disinfection of the hands. He serves in many national and international advisory roles and since 2019, he is president of International Society of Antimicrobial Chemotherapy (ISAC).

Serhat Unal is Professor of Medicine and previous Dean of the Hacettepe University School of Medicine in Ankara, Turkey. Prof. Unal has held various leadership positions including chair of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) European Study Group of Nosocomial Infections, Director of the Hacettepe University AIDS Treatment and Research Center, Ankara AIDS Prevention Society, Ankara Microbiology Society, and the Turkish Society of Internal Medicine. His research interests have been drug-resistant pathogens including methicillin-resistant staphylococci, vancomycin-resistant enterococci, penicillin-resistant pneumococci, adult vaccination, health care associated infections and HIV infection, and he has published over 200 papers in these fields. He is currently Secretary General for ISAC.

Jaime Oliver Vigueras is a Spanish doctor of medicine with more than 20 years’ experience in the pharmaceutical industry. Dr Vigueras started his career in Medical Devices at 3M Spain and before that, he practiced Emergency & General Medicine for two years. He has extensive experience working in biotechnology companies such as J&J, Roche, Novartis or Astellas and start-up companies such as Basilea Pharma or PregLem. He has focused on many different medical fields such as immunology, onco-hematology, reproductive medicine, ophthalmology, neuroscience, and recently, infection diseases and vaccines. He spent the majority of his career in pharma in local (Spain), regional (Europe and EMEA) and global medical roles. He is currently the Johnson & Johnson Senior Medical Director for Emerging Markets Region (Russia CIS, GCC, JENA, Turkey, MENA & Southern Africa) with responsibilities on the entire Johnson & Johnson portfolio.

Saul Faust is a Professor of Paediatric Immunology and Infectious Diseases and Director of the Southampton NIHR Wellcome Trust Clinical Research Facility. Professor Faust is currently Chair of the UK NIHR Medicines for Children Clinical Specialty Group Chairs' Forum and the Clinical Speciality Group for Allergy, Infectious Diseases and Immunity. He is Wessex Clinical Research Network Specialty Lead for Paediatrics and co-Director of the South Central Children’s Research Network (SoCCR). Current projects include work to bridge the clinical-laboratory interface in paediatric and adult infectious diseases, immunology and respiratory medicine (including biofilm-related clinical diseases), developing local and national collaborative clinical trials in paediatric infectious diseases, and conducting paediatric and adult vaccine trials as part of the UK academic paediatric vaccine group.